2nd Annual ACMA/DGE

Digital Strategy & Innovation for Medical Affairs

February 25-26, 2020

Philadelphia, PA

Event Overview

With a greater demand for deep scientific information across the healthcare community, it’s critical for medical affairs teams to up-skill and stay relevant as consumers use new channels to absorb information. Learn to transform your medical affairs department, implement progressive policies, push patient centricity, and determine what it takes to demonstrate value to internal and external stakeholders in a digital era.

For the 2nd Annual ACMA/DGE Digital Strategy & Innovation for Medical Affairs Summit, we’ve partnered with the brightest in the industry to build a program that focuses on the cultural digital transformation in medical affairs. Join us for the opportunity to participate in an interactive meeting that will help to identify best practices when implementing a digital strategy within your medical affairs team.

The Bellevue Hotel

Image

200 S Broad St.
Philadelphia, PA 19102
(215) 893-1234

Hotel Website

Special Event Rate
Book Now!

Top 5 Reasons to Attend

1. Use technology to make a cultural change within your company that focuses on collaboration
2. Understand how technology is changing the patients’ journey and where value can be found
3. Secure leadership support to make digital initiatives a priority
4. Learn how to manage the proliferation of data, while meeting demands for transparency
5. Gain the financial resources to advance Medical Affairs toward digital growth

Attendee Profile

This conference is designed for those involved in:

  • Medical Affairs
  • Clinical/Scientific Affairs
  • Medical Science Liaisons/MSLs
  • Medical Strategy/Communications
  • KOL/Thought Leader Relations/Engagement
  • Research Collaborations
  • Digital Innovation
  • Medical Information
  • Medical Education
  • Publication Planning
  • Health Economics and Outcomes Research/HEOR
  • Call Center Management
  • Patient Services
  • Medical/Scientific/Patient Communications

Tuesday, February 25th, 2020 | Day 1


8:00 AM - 9:00 AM

REGISTRATION & BREAKFAST

9:00 AM - 9:15 AM

ACMA Opening Remarks

William A. Soliman, PhD, BCMAS - Chairman
Accreditation Council for Medical Affairs (ACMA)

9:15 AM - 9:30 AM

Chairperson’s State of the Industry

Jill Massey, PharmD, MBA - SVP, Medical Affairs
Melinta Therapeutics, Inc.

9:30 AM - 10:15 AM

KEYNOTE: DIGITAL TRANSFORMATION: THE TIME IS NOW FOR MEDICAL AFFAIRS TO DRIVE A NEW MODEL OF ENGAGEMENT

  • Why should Medical Affairs incorporate Digital Advocacy into its infrastructure and how can we plan for impactful execution vs. digital for digital’s sake
  • How we can take inspiration from other industries when thinking about digital transformation
  • We need to reimagine the Medical Expert Customer Experience and incorporate design-thinking into our education and engagement strategy
  • The opportunity is ripe to leverage data and drive a more personalized approach to HCP education

Kunj Gohil, PharmD - Director & Digital Strategy Lead, Digital Medical Affairs
Novartis

10:15 AM - 11:15 AM

CO-PRESENTATION

MEDICAL INFORMATION DERIVATIVE CONTENT SUITE – INFOGRAPHICS, SLIDES, AUDIO MI LETTERS

  • Overview of information consumption preferences range from traditional text heavy letters to innovative and multichannel formats
  • Ability to have interactive content across various channels and serve multiple customer types
  • Ability to gather relevant KPIs and analytics on how the content is used as well as accessed leading to improvements in communication techniques

Divyesh Khetia - Head, Global Medical Information
GSK

EXTERNAL HCP GSK PORTALS – ADVANCES AND IMPORTANCE IN DIGITAL ENGAGEMENT

  • Central to the success of an external Medical Information portal is understanding the customer needs and currents gaps in how they access information
  • The convenience and accessibility of an external MI portal can improve the ability of HCPs to locate accurate and timely medical information and lead to better patient outcomes
  • Relevant KPIs and analytics are essential to gain buy-in from leadership and demonstrate a good return on investment
  • Strong partnership with legal and compliance is necessary for an effective risk mitigation strategy

Kevin Curtin - Head, US Medical Information
GSK

11:15 AM - 11:30 AM

NETWORKING & REFRESHMENT BREAK

11:30 AM - 12:00 PM

BAYER CASE STUDY
CASE STUDY: USE OF DIGITAL TECHNOLOGY TO ENHANCE MEDICAL AFFAIRS PROCESS EFFICIENCY AND COMPLIANCE

  • Medical processes are becoming complex because of increasing governance and compliance requirements
  • Process complexity also leads to inconsistency in how different teams follow and document the process
  • Digital platforms offer the possibility of reducing process complexity while enhancing consistency and compliance
  • An example of how a low-coding platform was used to digitize Advisory Boards and Learning Events processes will be provided

Shurjeel Choudhri BSc(med) MD FRCPC - SVP and Head, Medical & Scientific Affairs
Bayer Inc

12:00 PM - 1:00 PM

NETWORKING LUNCH

1:00 PM - 1:45 PM

THE MULTIDIMENTIONAL USE OF DIGITAL HEALTH ACROSS THE SPECTRUM OF LIFE SCIENCES

  • Discuss the shifting digital health/life sciences landscape
  • Delve into examples of digital health programs within life sciences and where they might lead
  • What are possible ways forward and mistakes we should learn from?

Shrawan Patel MD - Founder and CEO
Strategy.Health

1:45 PM - 2:45 PM

THE IMPACT OF DIGITAL VENUES ON STRATEGIC STAKEHOLDER ENGAGEMENT

  • Identify the logistical and resource barriers to domestic and global stakeholder engagement
  • Learn about innovative communication solutions that leading organizations utilize to overcome these challenges
  • Discuss how to use these solutions to deliver improved engagement outcomes while maintaining regulatory compliance

Jon Kaskey - Senior Director of Business Partnerships
Within3

Tehseen Salimi - Vice President of Medical Affairs and Real world Evidence
G1 Therapeutics, Inc.

2:45 PM - 3:00 PM

NETWORKING & REFRESHMENT BREAK

3:00 PM - 3:30 PM

DIGITAL MEDICAL ENGAGEMENT STRATEGIES

  • KOL/EE Pharma Journey
  • Describe traditional MSL Engagement Planning
  • Generational considerations and shifts
  • Knowledge Dilemma
  • Medical Engagement Framework

Allen Kumar - Senior Director, Medical Engagement Platforms
GlaxoSmithKline

3:30 PM - 4:00 PM

LEVERAGE DIGITAL TECHNOLOGY TO ENHANCE FIELD MEDICAL ENGAGEMENT AND MAXIMIZE IMPACT

  • Discuss how to connect a field medical team with your digital strategy
  • Utilize technology to identify and segment KOLs by scientific leadership indicators, research activities, referral patterns and population-based data points
  • Solidify and broaden KOL networks by identifying the right KOLs and their networks through use of big data
  • Effective use of digital technology to optimize field engagement and collection of scientific and clinical insights
  • Maintain and monitor engagement across KOL segments and through multiple avenues to maximize program results

Dan Hennessy - Vice President Field Medical Affairs
EMD Serono, Inc.

4:00 PM - 4:30 PM

EXECUTION OF DIGITAL STRATEGY FOR MEDICAL AFFAIRS - WHERE THE RUBBER MEETS THE ROAD!

  • In the rapidly changing digital era, success of Medical Affairs (MA) depends on successfully reinventing itself
  • to build competitive advantage in a fast-changing competitive landscape by seamlessly integrating digital technologies in their daily operations
    However, how capable are field medical professional teams to implement digital strategies? Companies often have big ambitions for digital strategy but when the rubber meets the road, implementation is a challenge How can field medical professional teams be armed to execute the MA Digital Strategy?
  • How can MA innovate development of a key resource, it’s people to add more relevant ‘medical value’ with transforming market demands?

Ajit Kulkarni PhD, MBA - Associate Director -MSL
Novartis Pharmaceuticals

4:30 PM - 4:45 PM

NETWORKING & REFRESHMENT BREAK

4:45 PM - 5:15 PM

HOW TO ACHIEVE TRUE PATIENT-CENTRICITY

  • Examining the digital footprint of private, patient-created online communities
  • Exploring how social listening can be used to capture the true patient voice
  • Collecting surrogate natural history data by retrospectively analyzing the vast amounts of social interaction within these groups
  • Discovering underrecognized symptoms hidden within these conversations
  • Publishing on anecdotal evidence to inform regulatory decision-making.
  • Integrating real-world case studies into the regulatory pathway

Maria Picone - CEO/ Co-Founder
TREND Community

5:15 PM - 5:45 PM

LEVERAGING NEW AND EXISTING COMMERCIAL AND MEDICAL SAAS TECHNOLOGIES TO BUILD A COMPLETE, MEDICAL AFFAIRS-OWNED, MEDICAL EDUCATION NETWORK

  • Does Medical Affairs have strong partners in the SaaS industry? Overview of the Clinical, Commercial and Medical Information System Landscape and how Medical Affairs can leverage SaaS technologies to drive successful digital strategies and implementations
  • Meeting the four critical areas for implementing a better system for scientific communication: Managing regulated content, automating engagement data for compliance and analytics, demonstrating value to the organization and making it work
  • Case Study: Using On-Demand CRM integrated Medical Education portals to support high-engagement programs with HCPs

Jason McCloyFounder
Entatio.com


Wednesday, February 26th, 2020 | Day 2


8:00 AM - 9:00 AM

NETWORKING & BREAKFAST

9:00 AM - 9:15 AM

Chairperson’s Recap of Day One

9:15 AM - 10:00 AM

HEOR AND RWE TO DRIVE VALUE FOR MEDICAL AFFAIRS

  • Discuss how medical affairs can implement an integrated evidence strategy and optimize evidence generation
  • Medical Affairs as the new key player in RWE 
  • Understand how real-world evidence can help to support a regulatory decision making 
  • Examine new trends in real world data generation 
  • Apply a patient-centric framework to develop a data generation plan

Aman H. Bhatti, MD VP - US & Global Medical Affairs 
AliveCor, Inc.

10:00 AM - 10:45 AM

Leverage Social Capital to Create Strategic Value

The hardest part of innovation is unlearning what you think you know. This session will explain why old engagement paradigms are inadequate and introduce new ways of thinking that take advantage of proliferating data and advanced analytics. Participants will learn how to drive immediate improvements within their organization. Specifically, attendees will leave with an understanding of:

  • What is social capital and how can you make it work for you?
  • How do you use social capital to create value and build consensus in the patient-provider community?
  • How can you integrate online and offline engagement strategies to create strategic synergies?

Anthony Page - CEO
Voxx Analytics

10:45 AM - 11:00 AM

NETWORKING & REFRESHMENT BREAK

11:00 AM - 11:45 AM

CO-PRESENTATION
MEDICAL AFFAIRS DIGITAL EVOLUTION AT A SMALL/MID-SIZE COMPANY

  • Why should small companies consider digital medical affairs?
  • Discuss how organizations who have not yet started on the digital transformation journey are now developing their initial plans and strategies
  • Undertaking the initiative to understand and propose a medical affairs digital strategy
  • Examine current challenges small companies may face today, based on different therapeutic areas and the state of the market

Diana Stefani-Hunyady, MD, PhD, MBA, BCMAS - Head of Global Medical Affairs
Viela Bio

Barry Lubarsky - Executive Director, Medical Affairs Strategy
Alkermes

11:45 AM - 12:30 PM

UTILIZING DIGITAL TO ENHANCE MEDICAL EDUCATION

Nami Pandit, PharmD, R.Ph - Global Medical Affairs Director 
Sanofi Genzyme

12:30 PM - 1:30 PM

NETWORKING LUNCH

1:30 PM - 2:15 PM

BIG(ISH)DATAANDARTIFICIALINTELLIGENCEFOR MEDICAL AFFAIRS

Big Data and Artificial Intelligence are often used but little understood terms. In this session, H1. will walk through the high level themes of Big Data and Artificial intelligence sharing ways that leveraging the two together allow for a greater ability to make challenging decisions.

  • High Level review of Big Data and AI
  • Examples of Big(ish) data and how it is already impacting medical Affairs
  • Applications and examples of ways to leverage these concepts
  • Where AI and Big Data will lead in the next 3-5 years

Robert Consalvo - Director of Strategic Commercial Engagement 
H1 Insights

2:15 PM - 3:00 PM

Session TBD

Kevin Millar - SVP, Creative & Medical Science
INVIVO Communications Inc.

3:00 PM - 3:30 PM

REGULATORY AND COMPLIANCE CONSIDERATIONS IN DIGITAL ERA

  • How collaboration between medical affairs and compliance professionals ensures companies drive medical communications toward a new future
  • Understand the relevant regulatory and enforcement framework
  • Describe how to mitigate risk in medical communications

Representative Invited - FDA

3:30 PM - 3:45 PM

Chairperson’s Closing Remarks

Jill Massey, PharmD, MBA - SVP, Medical Affairs
Melinta Therapeutics, Inc.


TWO DAYS OF EDUCATION AND OPPORTUNITY

DON'T MISS IT

REGISTER NOW

Featured Speakers


William Soliman

William Soliman

President
Accreditation Council for Medical Affairs (ACMA)

Surjeel Choulhri

Surjeel Choulhri

Senior Vice President and Head of Medical and Scientific Affairs
Bayer Inc.

Nami Pandit

Nami Pandit

Global Medical Affairs Director
Sanofi Genzyme

Kevin M. Curtin

Kevin M. Curtin

Head, US Medical Information
GSK

Div Khetia

Div Khetia

Global Head, Medical Information
GSK

 Dan Hennessy

Dan Hennessy

Vice President of Medical Affairs
EMD Serono

 Diana Stefani-Hunyady

Diana Stefani-Hunyady

 Kunj Gohil

Kunj Gohil

Allen Kumar

Allen Kumar

Sr. Director, Medical Engagement Platforms
GSK

Tony Page

Barry Lubarsky

Executive Director for Medical Affairs Strategy
Alkermes

Tony Page

Tony Page

CEO
Voxx Analytics

Tony Page

Jon Kaskey

Senior Director of Business Partnerships
Within3

Aman H. Bhatti

Aman H. Bhatti

MDVP, US & Global Medical Affairs
AliveCor, Inc.

Tony Page

Robert Consalvo

Director of Strategic Commercial Engagement
H1 Insights

Tony Page

Kevin Millar

SVP, Creative & Medical Science
Invivo

Jill Massey

Jill Massey

SVP, Medical Affairs
Melinta Therapeutics, Inc.

Shrawan Patel

Shrawan Patel

Founder and CEO
Strategy.Health

Tehseen Salimi

Tehseen Salimi

Vice President of Medical Affairs and Real World Evidence
G1 Therapeutics, Inc.

Ajit Kulkarni

Ajit Kulkarni

Associate Director -MSL
Novartis Pharmaceuticals

Maria Picone

Maria Picone

Co-Founder/CEO
TREND Community

REGISTRATION PRICING


CONFERENCE ATTENDEE

* EARLY BIRD *

Before 1/7/20

$1,796

STANDARD

Prior to Event

$1,996

ON-SITE

Register at Event

$2,196

Contact Amy Chapman at 561-571-7687 or achapman@dgevents.com
for pricing packages.

EVENT SPONSORS

SPONSOR THIS EVENT

Contact Amy Chapman at (561) 571.7687
or email achapman@dgeconfs.com


MEDIA PARTNERS

Image

PREMIER MEDIA PARTNER


Why Become Board Certified in Medical Affairs?

Image

Certification is becoming an important factor in the healthcare industry in general. A survey of over 1000 key opinion leaders (KOLs) found that over 90% preferred medical affairs professionals who had a Board Certified Medical Affairs Specialist (BCMAS) designation.

Several pharmaceutical companies also look at certification as a way to assess whether an individual possesses the skills and knowledge required for successful performance in a medical affairs role. Why are companies looking for this assurance? They want to hire the best of the best. By becoming board certified in your field of expertise, and by maintaining BCMAS, you are saying that you:

  • Have met standards that have been established and verified by a credible, accrediting body.
  • Are dedicated to maintaining quality of excellence in your profession.

These are powerful statements that speak volumes about you as a professional and the company or organization you represent. Board certification demonstrates that you are committed to your profession and that you want to continue to learn and grow.
Studies have shown that individuals who are certified in their field have higher salaries and better promotion opportunities.

Top 5 Reasons Why You Should Certify with the ACMA:

  1. Accredited: The ACMA is recognized nationally & internationally as a true mark of quality and excellence in the pharmaceutical industry for medical affairs professionals. The ACMA is accredited by the International Association for Continuing Education & Training (ANSI/IACET) which is the gold standard for certification & training around the world. Our program is administered and analyzed using the highest industry standards and state-of-the-art psychometric methodologies.
  2. Distinguish Yourself: Because ACMA offers multiple but related certificates, you can more readily become certified in more than one specialty, making you more valuable and marketable in the field.
  3. Go International: ACMA certification is widely accepted throughout the US as well as internationally with 25% of BCMAS graduates coming from outside the US.
  4. Expand Your Network: Once certified by ACMA you automatically become a member of the 75,000+ strong ACMA organization and gain access to a multitude of benefits, including discounts on continuing education, leadership opportunities, and access to a mentor to help you get ahead.
  5. Be on the cutting edge: ACMA board certification in medical affairs is the future of the life sciences and pharmaceutical industry.

Interested in BCMAS?

By attending any DGE/ACMA conference, receive 10% off of BCMAS registration.

Already BCMAS Certified? Receive 10% off your conference registration!